Meticulous Research®—a leading global market research company, published a research report titled, ‘Pharmaceutical Quality Management Systems Market by Solution Type (Deviation, CAPA, Audit, Risk & Compliance, Inspection, Document, Change, Training Management), Deployment Mode (Cloud, On-premise), and End User (Pharmaceutical, CDMO/CRO) - Global Forecast to 2030.’
Download Free Sample Report@ https://www.meticulousresearch.com/download-sample-report/cp_id=5398?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=18-09-2024
Meticulous Research® has released its latest report, projecting that the global pharmaceutical quality management systems market will reach a valuation of $3.97 billion by 2030, growing at a strong compound annual growth rate (CAGR) of 15.6%. The market's growth is driven by increasing drug manufacturing costs, the rising need for regulatory compliance, rapid industry expansion, and the benefits offered by software-based quality management systems. However, the high cost of implementing these systems remains a key challenge.
Opportunities and Challenges
The market is poised for substantial growth opportunities, spurred by the expanding markets for generic drugs and biopharmaceuticals, as well as the growing adoption of platform-as-a-service (PaaS) solutions by pharmaceutical companies. On the other hand, security concerns surrounding cloud-based deployments present a significant challenge.
Key Players
Leading companies in the pharmaceutical quality management systems market include:
- ANTARES VISION SpA (Italy)
- AssurX Inc. (U.S.)
- AXSource Consulting Inc. (U.S.)
- Körber AG (Germany)
- Compliance Quest, Inc. (U.S.)
- Dassault Systèmes SE (France)
- EtQ Management Consultants Inc. (U.S.)
- Honeywell International Inc. (U.S.)
- Ideagen PLC (U.K.)
- IQVIA HOLDINGS INC. (U.S.)
- Logic Gate Inc. (U.S.)
- MasterControl, Inc. (U.S.)
Market Segmentation
The global market is segmented into:
- Solution Type: Non-conformance/Deviation Management, CAPA Management, Audit Management, Risk & Compliance Management, Suppliers & Materials Management, Inspection Management, Document Management, Change Management, Training Management, and Other Solution Types.
- Deployment Mode: Cloud/Web-Based, On-Premise.
- End Users: Pharmaceutical and Biotechnology Companies, Contract Development Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs), Research Laboratories.
Solution Type Insights
In 2023, the non-conformance/deviation management segment is expected to lead the market in terms of share. This dominance is driven by the emphasis on managing non-conformance and deviations as outlined by industry standards like ISO 9001:2015. Implementing these controls helps organizations promptly identify and address quality issues, reducing operational disruptions. The regulatory significance of these processes further contributes to the segment's leading position.
End User Insights
Pharmaceutical and biotechnology companies are predicted to dominate the market, fueled by the growing demand for new drugs and therapies, extensive R&D activities, increased investments, and strong government support for biopharmaceutical research and manufacturing.
Geographic Insights
The report covers market analysis across several regions, including North America (U.S. and copyright), Europe (Germany, France, U.K., Italy, Spain, Ireland, Belgium, Netherlands, and the Rest of Europe), Asia-Pacific (China, Japan, India, Malaysia, Philippines, Vietnam, Singapore, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa. Asia-Pacific is anticipated to record the highest CAGR over the forecast period, driven by advancements in healthcare infrastructure, growing R&D activities, a large population base, and government initiatives to improve healthcare facilities.
About Meticulous Research®:
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments on “Pharmaceutical Quality Management Systems Industry to Reach $3.97 Billion by 2030”